Evidence map›Paper›PMID 30333201›Full record

ArticleBMJ case reports2018

A Rare case of recurrent Guillain-Barré syndrome without albuminocytological dissociation.

Anudeep Yelam, Elanagan Nagarajan, Raghav Govindarajan, Pradeep C Bollu

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Anudeep YelamDepartment of Neurology, University of Missouri Health Care, Columbia, Missouri, USA.
Elanagan NagarajanDepartment of Neurology, Howard Hughes Medical Institute-University of Missouri Columbia School of Medicine, Columbia, Missouri, USA.ORCID http://orcid.org/0000-0003-0521-9485
Raghav GovindarajanDepartment of Neurology, University of Missouri Health Care, Columbia, Missouri, USA.
Pradeep C BolluDepartment of Neurology, University of Missouri Health Care, Columbia, Missouri, USA.ORCID http://orcid.org/0000-0002-5364-4606
University of Missouri Health System · USHoward Hughes Medical Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guillain-Barré syndrome (GBS) is an immune-mediated polyneuropathy, often preceded by an illness. It is a self-limiting illness in most of the cases, but recurrence is rare and can be seen in about 1%-6% of patients. GBS is characterised by progressive, symmetrical, proximal and distal weakness. Areflexia and sensory disturbances are also common. Patients with GBS usually have albuminocytological dissociation on cerebrospinal fluid (CSF) analysis. This is a case of a 69-year-old woman with recurrent GBS and normal CSF findings.

Indexed as

AftercareAgedAlbuminsCerebrospinal FluidFemaleGuillain-Barre SyndromeHumansImmunoglobulins, IntravenousImmunologic FactorsRare DiseasesRecurrenceTreatment OutcomeAlbuminsImmunoglobulins, IntravenousImmunologic Factorsgeneral practice / family medicineimmunologyneurology (drugs and medicines)peripheral nerve disease

Identifiers

PMID30333201
PMCPMC6202978
OpenAlexW2897127214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.